<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>12</volume><submitter>Lai HY</submitter><pubmed_abstract>&lt;h4>Background&lt;/h4>Urothelial carcinoma (UC) patients often bear clinical and genetic heterogeneity, which may differ in management and prognosis. Especially, patients with advanced/metastatic UC generally have a poor prognosis and survive for only few months. The Wnt/β-catenin signaling is found to be highly activated in several cancers, including UC. However, accumulated evidence has shown discordance between the Wnt/β-catenin signaling and UC carcinogenesis. Accordingly, we aim to get a better understanding of the molecular characterization of UC, focusing on the Wnt signaling, which may add value to guiding management more precisely.&lt;h4>Patients and methods&lt;/h4>Clinical data and pathological features were retrospectively surveyed. The correlations of secreted Frizzled-related protein 2</pubmed_abstract><journal>Frontiers in oncology</journal><pagination>834249</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8965759</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>High Stromal SFRP2 Expression in Urothelial Carcinoma Confers an Unfavorable Prognosis.</pubmed_title><pmcid>PMC8965759</pmcid><pubmed_authors>Tseng WH</pubmed_authors><pubmed_authors>Kuo YH</pubmed_authors><pubmed_authors>Hsing CH</pubmed_authors><pubmed_authors>Tsai HH</pubmed_authors><pubmed_authors>Wu LC</pubmed_authors><pubmed_authors>Chiu CC</pubmed_authors><pubmed_authors>Li CF</pubmed_authors><pubmed_authors>Lai HY</pubmed_authors><pubmed_authors>Huang SK</pubmed_authors><pubmed_authors>Liu CL</pubmed_authors></additional><is_claimable>false</is_claimable><name>High Stromal SFRP2 Expression in Urothelial Carcinoma Confers an Unfavorable Prognosis.</name><description>&lt;h4>Background&lt;/h4>Urothelial carcinoma (UC) patients often bear clinical and genetic heterogeneity, which may differ in management and prognosis. Especially, patients with advanced/metastatic UC generally have a poor prognosis and survive for only few months. The Wnt/β-catenin signaling is found to be highly activated in several cancers, including UC. However, accumulated evidence has shown discordance between the Wnt/β-catenin signaling and UC carcinogenesis. Accordingly, we aim to get a better understanding of the molecular characterization of UC, focusing on the Wnt signaling, which may add value to guiding management more precisely.&lt;h4>Patients and methods&lt;/h4>Clinical data and pathological features were retrospectively surveyed. The correlations of secreted Frizzled-related protein 2</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022</publication><modification>2026-07-14T14:22:26.296Z</modification><creation>2026-06-19T03:07:31.717Z</creation></dates><accession>S-EPMC8965759</accession><cross_references><pubmed>35372028</pubmed><doi>10.3389/fonc.2022.834249</doi></cross_references></HashMap>